World

Almost three quarters of Australian adolescents experience depression or anxiety: study

Dec 18, 2024

Sydney [Australia], December 18: Almost three-quarters of adolescents in Australia experience clinically significant symptoms of depression or anxiety, research has found.
The research, published on Wednesday by Melbourne's Murdoch Children's Research Institute (MCRI), found that 74 percent of Australians reported experiencing clinically significant symptoms of depression or anxiety at least once across their adolescent years between the ages of 10 and 18.
Over 1,200 children from Melbourne enrolled in the study and had their symptoms of depression and anxiety tracked between 2012 and 2019.
Among the participants, 64 percent suffered from chronic depression or anxiety, which means they reported symptoms three or more times during their adolescence.
Girls were at increased risk, with 84 percent reporting depression or anxiety symptoms at least once compared to 61 percent of boys.
Ellie Robson, the lead author of the study from MCRI, described the results as concerning because mental health problems in adolescence can have serious lifelong health consequences.
"These are striking findings, particularly given how many young people experienced symptoms over multiple years of the study and how much depression and anxiety symptoms can affect young people's functioning and can have long-lasting negative health outcomes," she said in a media release.
The study found that the onset of depression and anxiety symptoms among adolescents increased at times that coincided with educational stress, such as the transition between primary and secondary schools, exams and the end of compulsory education.
Co-author Susan Sawyer said the findings represent the highest cumulative incidence of symptoms of mental disorders ever reported across adolescents from any country.
The research team will next examine the impact of reported symptoms on the health and functioning outcomes of contemporary adolescents.
Source: Xinhua

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025